Dermal fibrosis following subcutaneous injections of serotonin creatinine sulphate
The DOI matches its Crossref record.
Abstract
1) Serotonin creatinine sulphate was injected subcutaneously twice daily into rats in 8 mg doses for periods to 342 consecutive days. After approximately 30 days of injections there was observed a progressive collagenous and fibrous proliferation within the dermis, an increased vascularity, hyperplasia of the epidermis, vascular changes in arterioles of the dermis, and diminution in skin appendages, all at sites of serotonin injections. Control injections of physiologic saline and carbon tetrachloride did not result in similar changes. 2) The present findings appear to lend some support to the hypothesis that serotonin causes the cardiac valvular fibrosis observed in patients with the carcinoid syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Serotonin has long been implicated in fibrotic disorders; already in 1958 it was demonstrated that subcutaneous injections of serotonin induce skin fibrosis (159).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [159]
Citations
Cites
Still being checked.
Cited by
Platelet-derived serotonin links vascular disease and tissue fibrosis
Dees, C., Akhmetshina, A., Zerr, P., Reich, N., Palumbo, K., Horn, A., Jüngel, A., Beyer, C., Krönke, G., Zwerina, J., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101629 · Cited by 266
“Others proposed that 5-HT might be the cause of carcinoid-associated fi brosis ( MacDonald et al., 1958 ; Hallen, 1964 ).”
Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of Tryptophan
Silver, R. M., Heyes, M. P., Maize, J. C., Quearry, B., Vionnet-Fuasset, M., & Sternberg, E. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003293221302 · Cited by 245
Unraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
Development of a Scleroderma-like Illness during Therapy with L-5-Hydroxytryptophan and Carbidopa
Sternberg, E. M., Woert, M. H. V., Young, S. N., Magnussen, I., Baker, H., Gauthier, S. G., & Osterland, C. K. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010023031403 · Cited by 153
Cutaneous manifestations of the malignant carcinoid syndrome
Bell, H. K., Poston, G. J., Vora, J. P., & Wilson, N. J. E. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06273.x · Cited by 142
Duncan, S. C., & WINKELMANN, R. K. (1979) · PubMed · Cited by 128
Peripheral Serotonin Synthesis as a New Drug Target
Matthes, S., & Bader, M. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.03.004 · Cited by 113
Seibold, J. R., & Jageneau, A. H. M. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270204 · Cited by 115
Cellular and molecular mechanisms in fibrosis
Dees, C., Chakraborty, D., & Distler, J. H. W. (2020) · Experimental Dermatology · doi:10.1111/exd.14193 · Cited by 121
Scleroderma-like Lesions and the Carcinoid Syndrome
Fries, J. F. (1973) · Archives of Internal Medicine · doi:10.1001/archinte.1973.00320100078010 · Cited by 105
Serotonin paracrine signaling in tissue fibrosis
Mann, D. A., & Oakley, F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.009 · Cited by 109
Recent Research in the Field of 5-Hydroxytryptamine and Related Indolealkylamines
Erspamer, V. (1961) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7041-2_3 · Cited by 109
Varga, J., Peltonen, J., Uitto, J., & Jimenez, S. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-344 · Cited by 92
Inhibition of serotonin synthesis: A novel therapeutic paradigm
Bäder, M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107423 · Cited by 96
The Cause and Pathogenesis of the Eosinophilia-Myalgia Syndrome
Varga, J., Uitto, J., & Jiménez, S. A. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-2-140 · Cited by 84
The Role of Serotonin during Skin Healing in Post-Thermal Injury
Sadiq, A., Shah, A., Jeschke, M. G., Belo, C., Hayat, M. Q., Murad, S., & Amini‐Nik, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041034 · Cited by 89
Freundlich, B., Werth, V. P., Rook, A. H., O'Connor, C. R., Schumacher, H. R., Leyden, J. J., & Stolley, P. D. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-10-758 · Cited by 66
Mast cells as modulators of hair follicle cycling
Maurer, M., Paus, R., & Czarnetzki, B. M. (1995) · Experimental Dermatology · doi:10.1111/j.1600-0625.1995.tb00256.x · Cited by 65
Kaufman, L. D., Seidman, R., Phillips, M. E., & Gruber, B. L. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70334-e · Cited by 58
ADHD symptoms in neurometabolic diseases: Underlying mechanisms and clinical implications
Homaei, S. C., Halleland, H. B., Kleppe, R., Betari, N., Reif, A., & Haavik, J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.012 · Cited by 64
Love, L. A., Rader, J. I., Crofford, L. J., Raybourne, R. B., Principato, M., Page, S. W., Trucksess, M. W., Smith, M. J., Dugan, E. M., & Turner, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116300 · Cited by 52
5-Hydroxytryptamine and tryptamine pathways in scleroderma
Stachów, A., Jablonska, S., & Skiendzielewska, A. (1977) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1977.tb15060.x · Cited by 52
Blauvelt, A. (1991) · Archives of Dermatology · doi:10.1001/archderm.127.8.1159 · Cited by 51
Retroperitoneal Fibrosis and Ergot Derivatives
Stecker, J. F., Rawls, H. P., Devine, C. J. J., & Devine, P. C. (1974) · The Journal of Urology · doi:10.1016/s0022-5347(17)59635-4 · Cited by 50
Cosh, J., Cates, J. E., & Pugh, D. W. (1959) · Heart · doi:10.1136/hrt.21.3.369 · Cited by 46
Study of functional activit of adrenocortical cells with electron microscopy.
Ct, A., Gj, R., & Hh, M. H. (1959) · PubMed Central · Cited by 45
Hypersensitivity of scleroderma cutaneous vascular smooth muscle to 5-hydroxytryptamine
WINKELMANN, R. K., GOLDYNEAND, M. E., & Linscheid, R. L. (1976) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1976.tb15534.x · Cited by 39
Varga, J., Jiménez, S. A., & Uitto, J. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12356368 · Cited by 37
Varga, J., Jiménez, S. A., & Uitto, J. (1993) · Journal of Investigative Dermatology · doi:10.1038/jid.1993.31 · Cited by 36
A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).
Silver, R. M., Ludwicka, A., Hampton, M., Ohba, T., Bingel, S. A., Smith, T. N., Harley, R. A., Maize, J. C., & Heyes, M. P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117125 · Cited by 36
Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia–Myalgia syndrome
Silver, R. M., McKinley, K. L., Smith, E. A., Quearry, B. J., Harati, Y., Sternberg, E. M., & Heyes, M. P. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350916 · Cited by 35
Systemic Sclerosis - a Microvascular Disorder?
Jayson, M. I. V. (1983) · Journal of the Royal Society of Medicine · doi:10.1177/014107688307600804 · Cited by 35
Chaturvedi, S., Misra, D. P., Prasad, N., Rastogi, K., Singh, H., Rai, M. K., & Agarwal, V. (2018) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13386 · Cited by 37
Metastatic Cutaneous Carcinoid
Reingold, I. M. (1960) · Archives of Dermatology · doi:10.1001/archderm.1960.01580060127020 · Cited by 32
Skin and Muscle Indurations in Phenylketonuria
Jablonska, S. (1967) · Archives of Dermatology · doi:10.1001/archderm.1967.01600350005001 · Cited by 30
Kähler, H. J., & Heilmeyer, L. (1961) · Springer eBooks · doi:10.1007/978-3-642-94808-4_7 · Cited by 28
Bulpitt, K. J., Verity, M. A., Clements, P. J., & Paulus, H. E. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330702 · Cited by 25
Klein, R., & Berg, P. A. (1994) · Journal of Molecular Medicine · doi:10.1007/bf00207485 · Cited by 25
Takagi, H., Ochoa, M. S., Zhou, L., Helfman, T., Murata, H., & Falanga, V. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118265 · Cited by 24
Ketanserin in the treatment of systemic sclerosis: a double-blind controlled trial
Ortonne, J. ‐., TORZUOLI, C., Dujardin, P., & Fraitag, B. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb07791.x · Cited by 24
Systemic sclerosis: a collagen or microvascular disease?
Jayson, M. I. V. (1984) · BMJ · doi:10.1136/bmj.288.6434.1855 · Cited by 24
EOSINOPHILIC RHEUMATIC DISORDERS
Clauw, D. J., & Crofford, L. J. (1995) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00381-1 · Cited by 22
L-Tryptophan-Associated Eosinophilia-Myalgia Syndrome: Perspective of a New Illness
Kaufman, L. D., & Seidman, R. (1991) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00582-2 · Cited by 22
Role of neurotransmitters in the regulation of cutaneous wound healing
Gupta, D., Kaushik, D., & Mohan, V. (2022) · Experimental Brain Research · doi:10.1007/s00221-022-06372-0 · Cited by 21
Clinical Significance of Derangements of Tryptophan Metabolism
Fleischmajer, R. (1961) · Archives of Dermatology · doi:10.1001/archderm.1961.01580160027003 · Cited by 19
Vasculitis, Mast Cells and the Collagen Diseases
Smyth, C. J., & Gum, O. B. (1961) · Arthritis & Rheumatism · doi:10.1002/art.1780040102 · Cited by 19
Stern, R. H. (1971) · Springer eBooks · doi:10.1007/978-1-4615-7320-3_5 · Cited by 19
Malignant carcinoid syndrome associated with cutaneous scleroderma
Handley, J., Walsh, M., Armstrong, K., Russell, C. A., Buchananr, K., & Bingham, A. (1993) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1993.tb03535.x · Cited by 18
Dermal fibrosis in spinal cord injury patients
Stover, S. L., Gay, R. E., Koopman, W., Sahgal, V., & Gale, L. L. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780231115 · Cited by 17
MacDONALD, R. A. (1959) · PubMed Central · Cited by 17
Self-citationPathogenesis of scleroderma: The interrelationship of the immune and vascular hypotheses
Sternberg, E. M. (1985) · Survey of Immunologic Research · doi:10.1007/bf02918588 · Cited by 16
Eosinophilia/myalgia syndrome associated with L-tryptophan
Pfanner, T. P., Person, D., Berenberg, J., Gayle, E. L., Lockett, L. J., Schwartzberg, M., Weber, C., Graybiel, A., Harris, D., & Orth, R. (1990) · The Lancet · doi:10.1016/0140-6736(90)90638-l · Cited by 15
Serotonin—A Driver of Progressive Heart Valve Disease
Waldum, H. L., & Wahba, A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.774573 · Cited by 14
Progressive Systemic Sclerosis: Pseudoscleroderma
Fleischmajer, R., & Pollock, J. L. (1979) · Clinics in Rheumatic Diseases · doi:10.1016/s0307-742x(21)00063-1 · Cited by 14
Sclerodermoid Changes in a Patient with Metastatic Malignant Melanoma
Schwartz, R. A., Burgess, G. H., & Fox, M. D. (1980) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1980.tb00823.x · Cited by 13
Review of L-tryptophan and eosinophilia-myalgia syndrome
Roufs, J. (1992) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)00741-0 · Cited by 13
Clinical aspects of cerebral and extracerebral 5-hydroxytryptamine
Stacey, R. S. (1966) · Springer eBooks · doi:10.1007/978-3-642-85467-5_14 · Cited by 14
Stern, R. H. (1974) · Springer eBooks · doi:10.1007/978-1-4615-7323-4_11 · Cited by 13
Neurogenic Appendicitis: A Reappraisal of the Clinicopathological Features and Pathogenesis
Hussein, M. R., bshabshe, A. A. A. A., Elhakeem, A. A. E. A., & Elsamman, M. K. (2022) · Diagnostics · doi:10.3390/diagnostics12061386 · Cited by 15
Betari, N., Sahlholm, K., Ishizuka, Y., Teigen, K., & Haavik, J. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0127 · Cited by 13
Uitto, J., Varga, J., Peltonen, J. T. K., & Jiménez, S. A. (1992) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1992.tb03558.x · Cited by 11
Zbinden, G. (1960) · Springer eBooks · doi:10.1007/978-3-662-36743-8_4 · Cited by 10
Effect of Serotonin Inhibitors on Connective Tissue Disease: Experimental and Clinical Studies
Scherbel, A. L., & Schmid, E. (1962) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.29.1.1 · Cited by 10
Petrić, M., Perković, D., Božić, I., Krstulović, D. M., & Kaliterna, D. M. (2022) · Medicina · doi:10.3390/medicina58020161 · Cited by 8
Pseudoscleroderma and Phenylketonuria
Guillet, G., DORE, N., Hehunstre, J. P., Maleville, J., & Battin, J. (1983) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1983.tb02163.x · Cited by 8
Uniform vascular response to different aetiological factors
Beránek, J., & Ortonne, J. ‐. (1985) · Histopathology · doi:10.1111/j.1365-2559.1985.tb02848.x · Cited by 8
(2011) · Springer eBooks · doi:10.1007/springerreference_40975 · Cited by 7
Beele, H., Thierens, H., & Ridder, L. D. (1989) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02624005 · Cited by 6
THE EFFECT OF 5-HYDROXYTRYPTAMINE ON THE COTTON PELLET LOCAL INFLAMMATORY RESPONSE IN THE RAT
Bianchine, J. R., & Eade, N. R. (1967) · The Journal of Experimental Medicine · doi:10.1084/jem.125.3.501 · Cited by 6
Environmental fluoxetine promotes skin cell proliferation and wound healing
Rodriguez‐Barucg, Q., Garcia, A. A., García-Merino, B., Akinmola, T., Okotie-Eboh, T., Francis, T., Bringas, E., Ortíz, I., Wade, M., Dowle, A., et al. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124952 · Cited by 7
Serotonin and the 5-Hydroxyindole Pathway of Tryptophan Metabolism
Donaldson, R. M. (1959) · Archives of Internal Medicine · doi:10.1001/archinte.1959.00270080156022 · Cited by 4
A clinicopathological study of micronodular and macronodular cirrhosis in Belfast, Northern Ireland.
Sinniah, R. (1972) · PubMed Central · Cited by 3
Tuffanelli, D. L. (1963) · Journal of Investigative Dermatology · doi:10.1038/jid.1963.87 · Cited by 2
Grin, E., Šalamon, T., & Stern, P. (1964) · Archives of Dermatological Research · doi:10.1007/bf00522913 · Cited by 2
Pathophysiology of Scleroderma—A Review
Landau, J. W., & Newcomer, V. D. (1965) · International Journal of Dermatology · doi:10.1111/ijd.1965.4.1.2 · Cited by 2
Morphological changes caused by injections of 5-HT in animals and man
Stacey, R. S. (1966) · Springer eBooks · doi:10.1007/978-3-642-85467-5_13 · Cited by 1
Scleroderma as a Fibrotic Disorder
Huffstutter, J. E., & LeRoy, E. C. (1985) · Springer eBooks · doi:10.1007/978-1-4613-2493-5_15
Bases physiopathologiques des traitements de la sclérodermie systémique
Blétry, O., Francès, C., Cadranel, J. L., & Godeau, P. (1986) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(86)80017-0
Der Tryptophan-Stoffwechsel bei der progressiven Sklerodermie
Kreysel, H. W., Meyerhoff, K., & Kimmig, J. (1976) · Journal of Molecular Medicine · doi:10.1007/bf01483590
Sokoloff, B. (1968) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-99947-5_4
(1963) · Journal of Investigative Dermatology · doi:10.1038/jid.1963.29
Metadata
- Authors
- MacDonald, R. A., Robbins, S. L., & Mallory, G. K.
- Venue
- Experimental Biology and Medicine
- Publisher
- Frontiers Media SA
- Published
- 1958-02-01
- Volume
- 97
- Issue
- 2
- Pages
- 334-337
- ISSN
- 0071-3384 (ISSN-L)
- 1535-3702
- 1535-3699
- OpenAlex
- W2326519870
- Cited by
- 81
- References
- 0
- Citations by year
- 2024: 1 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 4 · 2012: 1
- FWCI
- 15.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Emergency Medicine › Intramuscular injections and effects
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Keywords
- skin fibrosis, subcutaneous injection, collagen proliferation, skin vascularity, epidermal hyperplasia, skin appendages, carcinoid syndrome, serotonin syndrome
- MeSH terms
- Creatinine, Drug Combinations, Humans, Injections, Subcutaneous, Serotonin, Skin, Skin Diseases, Sulfates, Serotonin Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.